| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Ventyx Biosciences, Inc.
13D/A
VTYX · 92332V107
|
6.0% |
1/9/2026
Event 1/7/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.